Innoviva to Participate in the Goldman Sachs Annual Global Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Innoviva, Inc. (NASDAQ:INVA – Get Rating)’s stock price was up 3.3% on Tuesday following insider buying activity. The company traded as high as $13.33 and last traded at $13.33. Approximately 164,464 shares traded hands during trading, a decline of 76% from the average daily volume of 678,851 shares. The stock had previously closed at $12.91. […]
StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Get Rating) from a hold rating to a buy rating in a research note published on Thursday morning. Several other analysts have also recently issued reports on the company. TheStreet cut Innoviva from a b- rating to a c+ rating in a research note on Thursday, February 23rd. […]
Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023Repurchased $40.3 million of common stock and paid off $96.2 million of 2023 convertible notesBURLINGAME, Calif. (BUSINESS WIRE) Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” o.
Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023
Repurchased $40.3 million of common stock and paid. | May 9, 2023